Terms: = Lung cancer AND BUB1B, BUBR1, 701, ENSG00000156970, SSK1, BUB1beta, MAD3L, hBUBR1, Bub1A, O60566 AND Prognosis
41 results:
1. Catalase Expression Is an Independent Prognostic Marker in lung Adenocarcinoma.
Chen PM; Huang YH; Chen HH; Chu PY
Anticancer Res; 2024 Jan; 44(1):287-300. PubMed ID: 38159982
[TBL] [Abstract] [Full Text] [Related]
2. Circulating miR-10b, soluble urokinase-type plasminogen activator receptor, and plasminogen activator inhibitor-1 as predictors of non-small cell lung cancer progression and treatment response.
Setiawan L; Setiabudy R; Kresno SB; Sutandyo N; Syahruddin E; Jovianti F; Nadliroh S; Mubarika S; Setiabudy R; Siregar NC
Cancer Biomark; 2024; 39(2):137-153. PubMed ID: 38073374
[TBL] [Abstract] [Full Text] [Related]
3. Clinical model of pulmonary metastasis in patients with osteosarcoma: A new multiple machine learning-based risk prediction.
Su Z; Huang F; Yin C; Yu Y; Yu C
J Orthop Surg (Hong Kong); 2023; 31(2):10225536231177102. PubMed ID: 37288764
[TBL] [Abstract] [Full Text] [Related]
4. Epidemiological and clinical characteristics of synchronous lung metastasis in major salivary gland mucoepidermoid carcinoma.
Li Y; Hu C
Eur Arch Otorhinolaryngol; 2023 Aug; 280(8):3835-3841. PubMed ID: 37100896
[TBL] [Abstract] [Full Text] [Related]
5. The Diagnostic and Prognostic Value of miR-155 in cancers: An Updated Meta-analysis.
Wu Y; Hong Q; Lu F; Zhang Z; Li J; Nie Z; He B
Mol Diagn Ther; 2023 May; 27(3):283-301. PubMed ID: 36939982
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic Index for Nonsmall Cell lung cancer Based on Immune-Related Genes Expression.
Cao Y; Zhu H; Shen H; Liu D; Li Z; Shang H; Du H; Wang Y; Ye J
Biomed Res Int; 2022; 2022():4779811. PubMed ID: 36193311
[TBL] [Abstract] [Full Text] [Related]
7. prognosis of resected non-small cell lung cancer with pleural plaques on intrathoracic findings.
Kagimoto A; Mimura T; Kamigaichi A; Yamashita Y
BMC Cancer; 2022 Apr; 22(1):469. PubMed ID: 35484615
[TBL] [Abstract] [Full Text] [Related]
8. Evaluation of the TRIP13 level in breast cancer and insights into potential molecular pathways.
Lan J; Huang J; Tao X; Gao Y; Zhang L; Huang W; Luo J; Liu C; Deng Y; Liu L; Liu X
J Cell Mol Med; 2022 May; 26(9):2673-2685. PubMed ID: 35322916
[TBL] [Abstract] [Full Text] [Related]
9. Value of the Controlling Nutritional Status score in predicting the prognosis of patients with lung cancer: A multicenter, retrospective study.
Liu XY; Zhang X; Zhang Q; Xie HL; Ruan GT; Liu T; Song MM; Ge YZ; Xu HX; Song CH; Shi HP
JPEN J Parenter Enteral Nutr; 2022 Aug; 46(6):1343-1352. PubMed ID: 34961947
[TBL] [Abstract] [Full Text] [Related]
10. KIAA0101 in Malignant Pleural Mesothelioma: A Potential Diagnostic and Prognostic Marker.
Lin P; Zhao Y; Li X; Liang Z
Comb Chem High Throughput Screen; 2022; 25(9):1498-1506. PubMed ID: 34238152
[TBL] [Abstract] [Full Text] [Related]
11. Prophylactic cranial irradiation confers favourable prognosis for patients with limited-stage small cell lung cancer in the era of MRI: A propensity score-matched analysis.
Li J; Ding C; Yang C; Wang S; Qiao X
J Med Imaging Radiat Oncol; 2021 Oct; 65(6):778-785. PubMed ID: 34159731
[TBL] [Abstract] [Full Text] [Related]
12. Identification of DNA methylation biomarkers for risk of liver metastasis in early-stage colorectal cancer.
Li W; Guo L; Tang W; Ma Y; Wang X; Shao Y; Zhao H; Ying J
Clin Epigenetics; 2021 Jun; 13(1):126. PubMed ID: 34108011
[TBL] [Abstract] [Full Text] [Related]
13. Evaluation of clinical value and potential mechanism of MTFR2 in lung adenocarcinoma via bioinformatics.
Chen C; Tang Y; Qu WD; Han X; Zuo JB; Cai QY; Xu G; Song YX; Ke XX
BMC Cancer; 2021 May; 21(1):619. PubMed ID: 34039308
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic and clinicopathological value of bub1b expression in patients with lung adenocarcinoma: a meta-analysis.
Chen J; Liao Y; Fan X
Expert Rev Anticancer Ther; 2021 Jul; 21(7):795-803. PubMed ID: 33764838
[TBL] [Abstract] [Full Text] [Related]
15. Establishment and Validation of Novel Clinical prognosis Nomograms for Luminal A Breast cancer Patients with Bone Metastasis.
Tu Q; Hu C; Zhang H; Peng C; Kong M; Song M; Zhao C; Wang Y; Li J; Zhou C; Wang C; Ma X
Biomed Res Int; 2020; 2020():1972064. PubMed ID: 33490234
[TBL] [Abstract] [Full Text] [Related]
16. Identification of potential target genes and crucial pathways in small cell lung cancer based on bioinformatic strategy and human samples.
Chen X; Wang L; Su X; Luo SY; Tang X; Huang Y
PLoS One; 2020; 15(11):e0242194. PubMed ID: 33186389
[TBL] [Abstract] [Full Text] [Related]
17. Risk and prognosis factors for systemic sclerosis with lung cancer: A single-centre case-control study in China.
Zhong H; Zhou J; Zhang S; Xu Y; Hou Y; Li M; Xu D; Wang M; Zeng X
Int J Clin Pract; 2021 Apr; 75(4):e13819. PubMed ID: 33159416
[TBL] [Abstract] [Full Text] [Related]
18. Construction and investigation of a combined hypoxia and stemness index lncRNA-associated ceRNA regulatory network in lung adenocarcinoma.
Guo L; Li H; Li W; Tang J
BMC Med Genomics; 2020 Nov; 13(1):166. PubMed ID: 33148251
[TBL] [Abstract] [Full Text] [Related]
19. Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma.
Zheng W; Zhu W; Yu S; Li K; Ding Y; Wu Q; Tang Q; Zhao Q; Lu C; Guo C
BMC Cancer; 2020 Nov; 20(1):1066. PubMed ID: 33148204
[TBL] [Abstract] [Full Text] [Related]
20. Identification of key genes and biological pathways in lung adenocarcinoma via bioinformatics analysis.
Wang Y; Zhou Z; Chen L; Li Y; Zhou Z; Chu X
Mol Cell Biochem; 2021 Feb; 476(2):931-939. PubMed ID: 33130972
[TBL] [Abstract] [Full Text] [Related]
[Next]
